Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

6.45
-0.1350-2.05%
Volume:11.08M
Turnover:72.92M
Market Cap:2.59B
PE:-3.81
High:6.77
Open:6.36
Low:6.33
Close:6.58
Loading ...

BRIEF-Recursion Pharmaceuticals Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing

Reuters
·
13 Feb

Recursion Pharmaceuticals files automatic mixed securities shelf

TIPRANKS
·
13 Feb

Recursion Pharmaceuticals Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
13 Feb

Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to Consider

Zacks
·
12 Feb

Analysts Conflicted on These Healthcare Names: Eli Lilly & Co (LLY), Recursion Pharmaceuticals (RXRX) and Labcorp Holdings (LH)

TIPRANKS
·
11 Feb

Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows Progress

TIPRANKS
·
09 Feb

Why Recursion Pharmaceuticals (RXRX) Stock Went Down On Thursday?

Insider Monkey
·
07 Feb

Recursion Pharmaceuticals Price Target Maintained With a $11.00/Share by Needham

Dow Jones
·
07 Feb

Promising Phase II Results for Recursion Pharmaceuticals’ REC-994 Bolster Buy Rating

TIPRANKS
·
07 Feb

Stock Track | Recursion Pharmaceuticals Soars 5% Pre-Market on Promising Phase 2 Data for Lead Candidate REC-994 in Cerebral Cavernous Malformations

Stock Track
·
06 Feb

BRIEF-Recursion Presents Phase 2 Data For REC-994 in CCM

Reuters
·
06 Feb

Recursion Presents Phase 2 Data for Rec-994 in Ccm in Late-Breaking Oral Presentation at the International Stroke Conference

THOMSON REUTERS
·
06 Feb

Recursion Pharmaceuticals (RXRX) Ascends While Market Falls: Some Facts to Note

Zacks
·
04 Feb

Recursion Pharmaceuticals call volume above normal and directionally bullish

TIPRANKS
·
31 Jan

Institutional owners may consider drastic measures as Recursion Pharmaceuticals, Inc.'s (NASDAQ:RXRX) recent US$130m drop adds to long-term losses

Simply Wall St.
·
30 Jan

Stock Track | Recursion Pharmaceuticals Plummets 5.05% Amid AI Market Volatility and Healthcare Tech Concerns

Stock Track
·
30 Jan